Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
25-26 September, 2025
Not Confirmed
Not Confirmed
29 September-02 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
25-26 September, 2025
Industry Trade Show
Not Confirmed
29 September-02 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
10 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250910173678/en/Mirum-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
08 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250908440307/en/Mirum-Pharmaceuticals-Announces-Enrollment-Completion-in-the-Phase-2b-VISTAS-Study
27 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250827209333/en/Mirum-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences
06 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250806722261/en/Mirum-Pharmaceuticals-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update
30 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250730907656/en/Mirum-Pharmaceuticals-to-Announce-Second-Quarter-2025-Financial-Results-and-Host-Conference-Call-on-August-6-2025
10 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250710074037/en/Mirum-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE